a public good project by the
Synthesis
Company
of California

© 2026

Fengxia Xue | doi.page

0 works0 citations0 h-index

Fengxia Xue

Tianjin Medical University General Hospital(CN)Tianjin Medical University(CN)

Publications by Year

Research Areas

Endometrial and Cervical Cancer Treatments, Reproductive tract infections research, Ovarian cancer diagnosis and treatment, Reproductive System and Pregnancy, Cervical Cancer and HPV Research

Most-Cited Works

→ CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks(2015)464 cited
→ Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis(2016)214 cited
→ Exon 3 mutations ofCTNNB1drive tumorigenesis: a review(2017)211 cited
→ CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis(2010)189 cited
→ Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy(2009)179 cited
→ Insulin resistance: A significant risk factor of endometrial cancer(2012)178 cited
→

ALDH1 expression correlates with favorable prognosis in ovarian cancers

(2009)

152 cited

→ Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions(2014)130 cited

→ Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers(2015)124 cited

→ MiR‐506 suppresses proliferation and induces senescence by directly targeting the CDK4/6–FOXM1 axis in ovarian cancer(2014)119 cited